SEGMENT INFORMATION (Tables)

6 Months Ended

Jan. 31, 2013

The following table presents sales and segment profit from continuing operations by business segment reconciled to earnings from continuing operations before income taxes, for the three and six months ended January 31, 2013 and January 31, 2012. The Life Sciences and Industrial results for the three and six months ended January 31, 2012 have been restated to reflect the change in allocation of certain shared expenses on a continuing operations basis.



	Three Months Ended				Six Months Ended
	Jan 31, 2013		Jan 31, 2012		Jan 31, 2013		Jan 31, 2012
SALES:
Life Sciences	$	329,182	$	299,231	$	629,133	$	600,985
Industrial	333,273		340,816		660,922		690,324
Total	$	662,455	$	640,047	$	1,290,055	$	1,291,309
SEGMENT PROFIT:
Life Sciences	$	82,477	$	78,088	$	152,319	$	157,805
Industrial	48,104		48,129		100,870		91,764
Total segment profit	130,581		126,217		253,189		249,569
Corporate Services Group	18,026		17,678		32,091		33,379
Operating profit	112,555		108,539		221,098		216,190
ROTC	4,399		5,156		8,673		28,140
Interest expense, net	6,017		5,386		5,449		11,331
Earnings from continuing operations before income taxes	$	102,139	$	97,997	$	206,976	$	176,719

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details